Series - Raising Capital

This webinar will help BIO 2024 attendees/exhibitors better prepare for their on-site experience at the event. We will provide important and practical on-site information, including programming and interactive event opportunities, as well as further instruction on how to more effectively use advanced features of the BIO One-on-One Partnering™ and Exhibitor platforms.

Gain valuable insights to make the most out of your participation at the upcoming BIO International Convention in San Diego this June!

To learn more about attending BIO 2024, visit http://convention.bio.org

The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Position yourself for success at this year's event, June 3-6, in San Diego! BIO is where business and breakthroughs converge – and the BIO One-on-One Partnering™ system facilitates the connections that fuel our industry.

Attend this webinar to learn more about what’s happening at BIO 2024 and what the BIO One-on-One Partnering™ system can do for your business goals. Explore the program, networking opportunities, partnering system fundamentals, gain insight to best practices for partnering, and much more! For more information and to register for BIO 2024, please visit: convention.bio.org

Join BIO staff as they walk exhibitors through the tools needed to plan for BIO International 2024!

The goal of this webinar is to provide our exhibitors with the resources to have an impactful presence in San Diego as well as provide additional details.

The following topics will be discussed:

• Exhibitor Dashboard
• Exhibitor Resources
• Exhibitor Partnering
• Important Dates and Deadlines
• Frequently Asked Questions (FAQs)

Announcements around and during JPM Week each January often create waves throughout the biotechnology ecosystem. View this Biotechnology Innovation Organization (BIO) webinar to learn what experienced dealmakers and market analysts found most relevant and influential from JPM Week to consider when planning your own capital formation and partnering priorities for 2024. The discussion covers developments affecting M&A trends, the IPO window, licensing trends, biotech AI, and investor sentiment.

This webinar will also preview the program for the BIO CEO & Investor Conference, February 26-27, and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities.

Want to learn more about events happening during JPM Week 2024 and how you can better navigate (and survive) it all?
 
View this webinar to get a grasp of all your options for networking and educational opportunities, hear from two panelists on how they approach this busy week, and start planning with BIO & Novateur's Event Guide to JPM 2024, a free mobile app. This webinar covers:
 
—Tips & tricks to make the most of JPM Week
—Receptions and other networking opportunities
—Conferences, presentations and other educational events
—Overview of BIO and Novateur Ventures’ JPM Week Events Guide mobile app
—BIO’s onsite meeting space in San Francisco and BIO Partnering at JPM Week

Looking for an efficient and effective way to source new partnerships and manage your meetings for JPM Week? This webinar explains how BIO One-on-One Partnering™ can help. Learn about BIO’s onsite meeting space in San Francisco, tips and tricks for using the system, and how to schedule your meetings with different location options. Also, get a look at how you can stay in-the-know about networking and other opportunities during JPM Week.

For more information about BIO Partnering at JPM Week, please visit: https://www.bio.org/events/bio-partnering-jpm

This webinar covers the following: 
- Preview of BIO’s onsite meeting space in San Francisco 
-Partnering best practices & how to schedule your meetings
- Live demo of the partnering system & advanced features
- Intro to BIO and Novateur Ventures’ JPM Week Events Guide mobile app
- Q&A with the host

Quick Links:

1. Copy of today’s slides: PowerPoint Presentation (bio.org)
2. Registration rates & where to register: https://bpjw.bio.org/registration
3. 2024 Participating companies: https://bpjw.bio.org/participating-companies
4. 2024 Participating investors: https://bpjw.bio.org/bio-one-one-partnering/participating-investors
5. Guide to JPM’24 mobile app for iPhone: https://apps.apple.com/mu/app/guide-to-jpm23/id1494244381
6. Guide to JPM’24 mobile app for Android: https://play.google.com/store/apps/details?id=org.novateur.ConferenceGuide
7. Submit your JPM Week event for our mobile app & Dec 12 webinar event list: https://forms.office.com/pages/responsepage.aspx?id=FmEqTcAdB0iptW1DmWAlb-7aiIadk1dGqhpdctNwLzRUM0pDVkYzQVlDTFJTQUJJMVpWTUVPSFUzSi4u
8. Register for the Dec 12^th JPM Networking Webinar: https://www.bio.org/webinars/raising-capital/bios-jpm-week-events-networking-preview

Big4Bio has heard your concerns loud and clear, and their pre-JPM Week/BioWeekSF online webinar, sponsored by BIO (Biotechnology Innovation Organization), is here to provide solutions and insights that will transform your JPM2024 experience. 

The panelists are industry experts who understand your pain points and provided actionable solutions:
– Dawn Bell, PharmD, Founder/Director, Myracle Therapeutics
– Kimberly Ha, Founder & CEO, KKH Advisors
– Chris Garabedian, Chairman & CEO, Xontogeny
– Lindy Fishburne, Managing Partner, Breakout Ventures

and BIO Partnering at JPM Week context from
– Mackensie Vernetti, Vice President, Partnering, Biotechnology Innovation Organization (BIO)

Following reauthorization by Congress of the SBIR/STTR Programs in 2022, there are new rules companies should familiarize themselves with concerning required disclosures of foreign affiliations or relationships with foreign countries. In addition to mandating disclosures prior to receiving SBIR awards, companies must also regularly update NIH following any changes to a disclosure. View this webinar organized by the Biotechnology Innovation Organization (BIO) for a comprehensive discussion on how to effectively navigate these new rules as you apply for SBIR awards.

This webinar is co-hosted by the National Institutes of Health (NIH) Seed Office.

With the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for commercialization is critical to bringing new treatments to patients. Surveys of academic tech transfer offices and the biopharma industry executives working on such alliances cite as obstacles two highly controllable factors: disagreement about alliance performance metrics and misalignment of deal terms priorities. This panel discusses best practices for removing such obstacles to accelerate more promising ideas into clinical development for patients.

BIO's updated 2023 report, "U.S. Biotechnology Translational Research: Partnership Models, Management Principles, and Best Practices," is available for download at the link below.  The webinar also summarizes major findings from that BIO report as context for the panel discussion and audience Q&A.